We are live on
!
Find out more
APM
Avidity Partners Management Portfolio holdings
AUM
$936M
1-Year Est. Return
195%
This Fund
S&P 500
This Quarter
Est. Return
+54.86%
1 Year Est. Return
+195%
3 Year Est. Return
+460.87%
5 Year Est. Return
+815.5%
10 Year Est. Return
–
AUM
$1.56B
AUM Growth
+$863M
(+124%)
Cap. Flow
+$618M
Cap. Flow
% of AUM
39.64%
Top 10 Holdings %
Top 10 Hldgs %
44.99%
Holding
83
New
33
Increased
20
Reduced
4
Closed
25
Top Buys
| 1 |
AbbVie
ABBV
|
+$94.1M |
| 2 |
Baxter International
BAX
|
+$69.8M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.6M |
| 4 |
Arvinas
ARVN
|
+$45.7M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
+$41.5M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$49.1M |
| 2 |
Merck
MRK
|
+$37.9M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$25.5M |
| 4 |
Cardinal Health
CAH
|
+$24.2M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$22.7M |
Sector Composition
| 1 | Healthcare | 91.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AbbVie
ABBV
$431B
| $152M | 9.72% |
1,545,400
+1,068,400
| +224% | +$94.1M |
|
|
2
Regeneron Pharmaceuticals
REGN
$69.7B
| $82.4M | 5.28% |
132,100
+82,100
| +164% | +$46.6M |
|
|
BHVN
3
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $80.8M | 5.18% |
1,104,500
+564,500
| +105% | +$30M |
|
|
4
Baxter International
BAX
$11.4B
| $69M | 4.42% |
+800,900
| New | +$69.8M |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| $67.7M | 4.34% |
1,911,300
+1,418,300
| +288% | +$41.5M |
|
6
Exelixis
EXEL
$14B
| $64M | 4.1% |
2,694,070
+1,608,070
| +148% | +$37.3M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals
ALXN
| $57M | 3.65% |
507,700
+347,700
| +217% | +$36.9M |
|
|
HOLX
8
DELISTED
Hologic
HOLX
| $46.6M | 2.99% |
+817,200
| New | +$40.1M |
|
|
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
| $42.6M | 2.73% |
250,900
-329,100
| -57% | -$49.1M |
|
10
Aurinia Pharmaceuticals
AUPH
$2.07B
| $40.2M | 2.58% |
2,474,599
+1,292,599
| +109% | +$20.7M |
|
|
MNTA
11
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $38.3M | 2.45% |
1,150,000
+370,000
| +47% | +$11.8M |
|
|
CCXI
12
DELISTED
ChemoCentryx, Inc.
CCXI
| $37.2M | 2.38% |
645,800
+409,800
| +174% | +$22.3M |
|
|
13
Arvinas
ARVN
$534M
| $36.1M | 2.32% |
+1,076,900
| New | +$45.7M |
|
14
Axsome Therapeutics
AXSM
$12.2B
| $33.3M | 2.14% |
404,900
+207,900
| +106% | +$16M |
|
|
KDMN
15
DELISTED
Kadmon Holdings, Inc.
KDMN
| $32.9M | 2.11% |
6,426,700
+3,598,700
| +127% | +$16.1M |
|
|
PRNB
16
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $32.8M | 2.1% |
+548,500
| New | +$33.9M |
|
17
Zentalis Pharmaceuticals
ZNTL
$340M
| $32.4M | 2.08% |
+674,487
| New | +$25.9M |
|
|
HZNP
18
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $29.8M | 1.91% |
536,200
+203,200
| +61% | +$8.69M |
|
|
ESPR
19
DELISTED
Esperion Therapeutics
ESPR
| $28.7M | 1.84% |
559,700
+354,700
| +173% | +$14.8M |
|
20
Avantor
AVTR
$7.65B
| $27.4M | 1.76% |
+1,612,000
| New | +$26.2M |
|
21
Vir Biotechnology
VIR
$1.62B
| $25.4M | 1.63% |
+620,600
| New | +$20.8M |
|
|
MRSN
22
DELISTED
Mersana Therapeutics
MRSN
| $25M | 1.6% |
+42,784
| New | +$14.6M |
|
|
DVAX
23
DELISTED
Dynavax Technologies
DVAX
| $23.7M | 1.52% |
2,674,154
-1,149,846
| -30% | -$5.81M |
|
24
Syndax Pharmaceuticals
SNDX
$2.08B
| $22.6M | 1.45% |
+1,527,400
| New | +$23.3M |
|
25
Neurocrine Biosciences
NBIX
$17.3B
| $22.6M | 1.45% |
185,100
+87,100
| +89% | +$9.63M |
|
Similar funds
NM
LM
IF
PWAM
CM
LJAC
PO
SH